Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners

被引:42
|
作者
Brown, Kelly A. [1 ]
Samuel, Sharmeen [1 ]
Patel, Dilip R. [1 ]
机构
[1] Western Michigan Univ, Homer Stryker MD Sch Med, Dept Pediat & Adolescent Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA
关键词
Attention-deficit/hyperactivity disorder (ADHD); stimulants; non-stimulant medication; methylphenidate; amphetamine; alpha-2-agonists; DEFICIT/HYPERACTIVITY DISORDER; CARDIOVASCULAR EVENTS; STIMULANT-DRUGS; UNITED-STATES; ADHD DRUGS; ATOMOXETINE; METHYLPHENIDATE; SAFETY; PHARMACOTHERAPY; RELEASE;
D O I
10.21037/tp.2017.08.02
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder in children and adolescents. ADHD affects multiple aspects of an individual's life and functioning in family, social, and academic realms. Effective management of ADHD is necessary for children and adolescents and may include non-pharmacologic treatments, pharmacologic therapy including use of stimulant and non-stimulant medications, or a combination of the different treatment modalities. In general, medications used to treat ADHD are safe and effective. Medical practitioners can follow a step-wise approach in the selection and adjustment of pharmacologic agents to treat ADHD, while working closely with families, caregivers, and other medical and educational professionals to form appropriate treatment plans. This article reviews practical aspects of pharmacological treatment of ADHD in children and adolescents.
引用
收藏
页码:36 / 47
页数:12
相关论文
共 50 条
  • [1] Non-pharmacologic management of attention-deficit/hyperactivity disorder in children and adolescents: a review
    Shrestha, Mahesh
    Lautenschleger, Julianna
    Soares, Neelkamal
    TRANSLATIONAL PEDIATRICS, 2020, 9 : 114 - 124
  • [2] Polypharmacy in the Management of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Review and Update
    Baker, Megan
    Huefner, Jonathan C.
    Bellonci, Christopher
    Hilt, Robert
    Carlson, Gabrielle A.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2021, 31 (03) : 148 - 163
  • [3] Attention deficit hyperactivity disorder in children and adolescents
    Flisher, A. J.
    Hawkridge, S.
    SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2013, 19 (03) : 136 - 140
  • [4] Review of lisdexamfetamine dimesylate in children and adolescents with attention deficit/hyperactivity disorder
    Najib, Jadwiga
    Didenko, Ekaterina
    Meleshkina, Daria
    Yusupov, Kamila
    Maw, Kateryna
    Ramnarain, Justin
    Tabassum, Maliha
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1717 - 1735
  • [5] MANAGEMENT FUNCTIONS IN ADOLESCENTS WITH DISORDER OF ATTENTION DEFICIT WITH HYPERACTIVITY DISORDER
    Rincon Lozada, Carlos Francisco
    Rey Anacona, Cesar Armando
    REVISTA ARGENTINA DE CLINICA PSICOLOGICA, 2014, 23 (01) : 5 - 14
  • [6] Attention deficit hyperactivity disorder (ADHD) in children and adolescents
    Said, Zead
    Huzair, Hifzi
    Helal, Muhammad Nabeel
    Mushtaq, Imran
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2015, 19 (03) : 16 - 23
  • [7] Attention Deficit-Hyperactivity Disorder in Children and Adolescents
    Feldman, Heidi M.
    Reiff, Michael I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (09): : 838 - 846
  • [8] Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Carbray, Julie A.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (12) : 7 - 10
  • [9] Amphetamines for attention deficit hyperactivity disorder in children and adolescents
    Feldman, Mark E.
    PAEDIATRICS & CHILD HEALTH, 2017, 22 (05) : 288 - +
  • [10] Attention-deficit/hyperactivity disorder in children and adolescents
    Dunn, DW
    Kronenberger, WG
    NEUROLOGIC CLINICS, 2003, 21 (04) : 933 - +